NEW YORK (GenomeWeb) – Cellular Dynamics on Tuesday filed a shelf registration to offer up to $90 million in securities.
In the document filed with the US Securities and Exchange Commission, the company, which raised $43 million when it went public in July 2013, said it may offer from time to time shares of its common stock, preferred stock, warrants to purchase its common or preferred stock, and debt securities, as well as a combination of the securities. Proceeds from any sale are planned for general corporate use, including working capital and/or capital expenditures, the Madison, Wis.-based stem cell technologies firm said.
Last month Cellular Dynamics said that revenues for the second quarter rose 29 percent year over year to $3.6 million. It had $47.4 million in cash and cash equivalents as of June 30.
In afternoon trading, shares of the company were down more than 2 percent on the Nasdaq at $10.80.